AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹920 Cr | ₹816 Cr | ₹588 Cr | ₹713 Cr | ₹654 Cr |
What is the latest Consolidated Net Profit of AJANTA PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹920 Cr |
| Mar2025 | ₹816 Cr |
| Mar2024 | ₹588 Cr |
| Mar2023 | ₹713 Cr |
| Mar2022 | ₹654 Cr |
How is Consolidated Net Profit of AJANTA PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹920 Cr | 12.77 | |
| Mar2025 | ₹816 Cr | 38.81 | |
| Mar2024 | ₹588 Cr | -17.50 | |
| Mar2023 | ₹713 Cr | 8.99 | |
| Mar2022 | ₹654 Cr | - | |
Compare Consolidated Net Profit of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹42,106.3 Cr | -1.5% | 14.4% | 31.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -1.5% |
14.4% |
31.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses